Theranexus (EPA:ALTHX) | WebDisclosure

Basculer en Français

9475	Companies
185451	Keywords
117789	Articles
99301	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 05/13/2025 at 18:00, 6 months 22 days ago

THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION ANNOUNCE STRONG POSITIVE REAL-WORLD DATA SUPPORTING BATTEN-1 EFFICACY FOR THE TREATMENT OF BATTEN DISEASE
Theranexus and BBDF announce new data supporting Batten-1 (miglustat) efficacy for CLN3 disease treatment. Results show significant preservation of visual acuity in treated patients over 12 months. Real-world analysis aligns with Phase 3 trial design

Theranexus Batten-1 BBDF Visual Acuity CLN3 Disease
PRESS RELEASE

published on 05/13/2025 at 18:00, 6 months 22 days ago

THERANEXUS ET LA FONDATION BEYOND BATTEN DISEASE ANNONCENT DES DONNÉES EN VIE RÉELLE TRÈS POSITIVES SOUTENANT L'EFFICACITÉ DE BATTEN-1 DANS LE TRAITEMENT DE LA MALADIE DE BATTEN CLN3
Theranexus et la Fondation Beyond Batten Disease présentent des résultats prometteurs pour le traitement de la maladie de Batten-CLN3 avec le médicament Batten-1 (miglustat). Nouvelle étude en vie réelle montre une préservation de l'acuité visuelle

Theranexus Batten-1 Miglustat Fondation Beyond Batten Disease Traitement CLN3
BRIEF

published on 04/29/2025 at 19:05, 7 months 5 days ago

Theranexus : Bilan Annuel 2024 et Nouvelles Perspectives

Résultats Financiers Partenariats Theranexus Batten-1 Subventions
BRIEF

published on 04/29/2025 at 19:05, 7 months 5 days ago

Theranexus: 2024 Annual Review and New Perspectives

Financial Results Partnerships Theranexus Batten-1 Grants
PRESS RELEASE

published on 04/29/2025 at 19:00, 7 months 5 days ago

THERANEXUS PUBLIE SES RÉSULTATS ANNUELS 2024, FAIT LE POINT SUR SES ACTIVITÉS ET CLÔTURE SA LIGNE DE FINANCEMENT
Theranexus publie ses résultats annuels 2024, fait le point sur ses activités et clôture sa ligne de financement. Détails sur Batten-1, PickASO, IMASO et partenariat avec Exeltis

Résultats Annuels Theranexus Batten-1 PickASO Exeltis
PRESS RELEASE

published on 04/29/2025 at 19:00, 7 months 5 days ago

THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT AND CLOSES ITS EQUITY LINE
Theranexus publishes financial results for 2024 & cash position as of March 31, 2025, presents progress report & plans for Batten-1 drug candidate. Board approves accounts. Continues strategic partnerships & developments

Financial Results Strategic Partnerships Clinical Trials Theranexus Batten-1
BRIEF

published on 03/06/2025 at 18:05, 8 months 29 days ago

Modification of the Theranexus liquidity contract

Liquidity Contract AMF PORTZAMPARC Theranexus Rare Neurological Diseases
BRIEF

published on 03/06/2025 at 18:05, 8 months 29 days ago

Modification du contrat de liquidité de Theranexus

Contrat De Liquidité AMF PORTZAMPARC Theranexus Maladies Neurologiques Rares
PRESS RELEASE

published on 03/06/2025 at 18:00, 8 months 29 days ago

MODIFICATION DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
Theranexus annonce une modification de contrat de liquidité afin de se conformer à la réglementation. Retrait de 50 000 euros. Bilan du 31/12/2024 et présentation de la société

Contrat De Liquidité Réglementation Theranexus Neurologie Batten
BRIEF

published on 01/31/2025 at 18:10, 10 months 4 days ago

Bilan semestriel du contrat de liquidité de Theranexus avec Portzamparc

Contrat De Liquidité Bilan Semestriel Transactions PORTZAMPARC Theranexus

Accesswire

Published on 12/05/2025 at 02:35, 9 hours 43 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 9 hours 48 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 11 hours 18 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 13 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 18 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 12:05, 13 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 18 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 18 minutes ago

Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 4 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 11:08, 1 hour 9 minutes ago

Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social

Les Echos

Published on 12/05/2025 at 08:45, 3 hours 33 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 3 hours 33 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 3 hours 36 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 18 hours 3 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 18 hours 18 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE